BRIEF-Bowman To Acquire Exeltech, Expanding Bridge Design And Transportation Engineering-March 2024-www.financetom.com

BRIEF-Bowman To Acquire Exeltech, Expanding Bridge Design And Transportation Engineering

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Bowman To Acquire Exeltech, Expanding Bridge Design And Transportation Engineering

Nov 4, 2024 11:49 AM

Oct 31 (Reuters) - Bowman Consulting Group Ltd ( BWMN ):

* BOWMAN TO ACQUIRE EXELTECH, EXPANDING BRIDGE DESIGN AND

TRANSPORTATION ENGINEERING

* BOWMAN CONSULTING GROUP LTD ( BWMN ) - ACQUISITION FINANCED WITH

CASH,

NOTES, AND CONVERTIBLE NOTE AT $32.32 PER SHARE

Source text:

Further company coverage:

Previous page： Kenvue Names Kirk Perry as Permanent CEO Next page： Honeywell appoints Jim Currier as CEO of aerospace unit

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Kenvue Names Kirk Perry as Permanent CEO

Nov 3, 2025

07:05 AM EST, 11/03/2025 (MT Newswires) -- Kenvue ( KVUE ) said Monday that it has named Kirk Perry as chief executive officer on a permanent basis, effective immediately. Perry had served as interim CEO since July 14 and will continue to serve as a non-independent member of the board, the company said. The company also said it has appointed...

Honeywell appoints Jim Currier as CEO of aerospace unit

Nov 3, 2025

Nov 3 (Reuters) - Honeywell ( HON ) said on Monday it has appointed Jim Currier as president and CEO of its aerospace unit, which will become a publicly traded company following its planned spin-off. ...

Axsome Therapeutics Q3 net product revenue jumps 63%

Nov 3, 2025

Overview * Axsome Q3 2025 net product revenue grows 63% yr/yr to $171 mln * AUVELITY Q3 2025 sales rise 69% yr/yr to $136.1 mln * Company submits sNDA for AXS-05 in Alzheimer's agitation to FDA Outlook * Axsome plans to initiate multiple Phase 3 trials in 4Q 2025 * Company expects cash to fund operations into cash flow positivity...

Asset management firm AMG misses Q3 revenue estimates

Nov 3, 2025

Overview * AMG Q3 revenue missed analyst expectations, while adjusted EBITDA beat estimates * Economic EPS for Q3 grew 27% yr/yr, reflecting strong capital allocation * Company reported $9 bln in net client cash inflows, driven by alternative strategies Outlook * AMG plans to leverage strong cash flow for growth investments * Company sees opportunities to enhance long-term growth prospects...